p27Kip1 Antibody (DCS-72.F6)

p27Kip1 Monoclonal Antibody for Western blot, IF, FACS, IP

>> See 16 other antibodies for CDKN1B (cyclin-dependent kinase inhibitor 1B)
Synonyms:
cyclin-dependent kinase inhibitor 1B
Details
Host / Isotype: Mouse / IgG1, kappa
Class: Monoclonal
Type: Antibody
Clone: DCS-72.F6
Tested Species Reactivity: Human (Hu), Mouse (Ms), Rat (Rt), Canine (Ca)
Published Species Reactivity: Human (Hu), Mouse (Ms), Not Applicable (N/A)
Immunogen: Mouse recombinant p27 protein
Ordering Information
Pierce p27Kip1 Antibody (DCS-72.F6)
Product #
MA5-12835
Size
500 ul
Price
$299.00
Purchase
Add p27Kip1 Antibody (DCS-72.F6) to your cart.
Tested Applications Dilution *
Western Blot (WB) 0.5-1.0 µg/ml
Immunofluorescence (IF) Assay Dependent
Flow Cytometry (FACS) 2 ug/test
Immunoprecipitation (IP) 2 µg/ml
Published Applications Dilution
Western Blot (WB) See publications below
Immunocytochemistry (ICC) See publications below
Immunohistochemistry (IHC) See publications below
Flow Cytometry (FACS) See publications below
Immunoprecipitation (IP) See publications below
* Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
Form Information
Form: Liquid
Concentration: 0.2mg/ml
Purification: Protein A
Storage Buffer: PBS, pH 7.4, with 0.2% BSA
Preservative: 15mM sodium azide
Storage Conditions: 4° C
Product Specific Information
MA5-12835 targets p27Kip1 in FACS, IF, IP, and WB applications and shows reactivity with Canine, Human, mouse, and Rat samples.

The MA5-12835 immunogen is mouse recombinant p27 protein.
General Information
p27Kip1, a candidate tumor suppressor gene, functions as a negative regulator of G1 progression and has been proposed to fuction as a possible mediator of TGF-beta induced G1 arrest.
Product Images
  • p27Kip1 Antibody (MA5-12835) in WB
    MA5-12835_WesternBlot.jpg

    Western Blot with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835) (MA5-12835_WesternBlot.jpg)

    Western Blot with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835)

    Western blot of p27Kip1 using p27Kip1 Monoclonal Antibody (MA5-12835) on LS174T Cells.
  • p27Kip1 Antibody (MA5-12835) in FACS
    MA5-12835_FACS_Hela_20130731125127.jpg

    Flow Cytometry with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835) (MA5-12835_FACS_Hela_20130731125127.jpg)

    Flow Cytometry with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835)

    Flow cytometry analysis of p27Kip1 in Hela cells (green) compared to an isotype control (blue). Cells were harvested, adjusted to a concentration of 1-5x10^6 cells/ml, fixed with 2% paraformaldehyde and washed with PBS. Cells were blocked with a 2% solution of BSA-PBS for 30 min at room temperature and incubated with a p27Kip1 monoclonal antibody (Product # MA5-12835) at a dilution of 2 ug/test for 60 min at room temperature. Cells were then incubated for 40 min at room temperature in the dark using a Dylight 488-conjugated goat anti-mouse IgG (H+L) secondary antibody and re-suspended in PBS for FACS analysis.
  • p27Kip1 Antibody (MA5-12835) in FACS
    MA5-12835_FACS_Jurkat_20130731125148.jpg

    Flow Cytometry with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835) (MA5-12835_FACS_Jurkat_20130731125148.jpg)

    Flow Cytometry with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835)

    Flow cytometry analysis of p27Kip1 in Jurkat cells (green) compared to an isotype control (blue). Cells were harvested, adjusted to a concentration of 1-5x10^6 cells/ml, fixed with 2% paraformaldehyde and washed with PBS. Cells were blocked with a 2% solution of BSA-PBS for 30 min at room temperature and incubated with a p27Kip1 monoclonal antibody (Product # MA5-12835) at a dilution of 2 ug/test for 60 min at room temperature. Cells were then incubated for 40 min at room temperature in the dark using a Dylight 488-conjugated goat anti-mouse IgG (H+L) secondary antibody and re-suspended in PBS for FACS analysis.
  • p27Kip1 Antibody (MA5-12835) in FACS
    MA5-12835_FACS_NIH-3T3_20130731125212.jpg

    Flow Cytometry with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835) (MA5-12835_FACS_NIH-3T3_20130731125212.jpg)

    Flow Cytometry with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835)

    Flow cytometry analysis of p27Kip1 in NIH-3T3 cells (green) compared to an isotype control (blue). Cells were harvested, adjusted to a concentration of 1-5x10^6 cells/ml, fixed with 2% paraformaldehyde and washed with PBS. Cells were blocked with a 2% solution of BSA-PBS for 30 min at room temperature and incubated with a p27Kip1 monoclonal antibody (Product # MA5-12835) at a dilution of 2 ug/test for 60 min at room temperature. Cells were then incubated for 40 min at room temperature in the dark using a Dylight 488-conjugated goat anti-mouse IgG (H+L) secondary antibody and re-suspended in PBS for FACS analysis.
  • p27Kip1 Antibody (MA5-12835) in IP
    MA5-12835_Immunoprecipitation.jpg

    Immunoprecipitation with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835) (MA5-12835_Immunoprecipitation.jpg)

    Immunoprecipitation with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835)

  • p27Kip1 Antibody (MA5-12835) in IP
    MA5-12835_Immunoprecipitation_1.jpg

    Immunoprecipitation with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835) (MA5-12835_Immunoprecipitation_1.jpg)

    Immunoprecipitation with anti-p27Kip1 Monoclonal Antibody [DCS-72.F6] (MA5-12835)

    Immunoprecipitation of p27Kip1 using p27Kip1 Monoclonal Antibody (MA5-12835) on Native Mouse MAD109 Cells.
Publications:
Western Blot
  Species / Dilution Summary
  Hu / Not Cited
MA5-12835 was used in flow cytometry, immunocytochemistry, and western blot to study changes in the expression of the 24kDa C-terminal p27kip1 variant upon lymphocyte activation

J Cell Biochem. 2001 Aug 21-Sep 5;83(3):380-9.
"Dynamic changes in p27kip1 variant expression in activated lymphocytes."
Author(s): Yaroslavskiy B, Watkins SC, Alber S, Steinman RA
Number of Citations: 1
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to study whether IGF-I interferes with the growth-inhibitory action of trastuzumab in breast cancer cells

J Natl Cancer Inst. 2001 Dec 19;93(24):1852-7.
"Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)."
Author(s): Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M
Number of Citations: 138
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in immunoprecipitation and western blot to study the mechanisms by which IGF-1 confers resistance to the growth-inhibiting actions of Herceptin

Int J Cancer. 2004 Jan 20;108(3):334-41.
"Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells."
Author(s): Lu Y, Zi X, Pollak M
Number of Citations: 26
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to study the mechanisms of action of intra-tumoral docetaxel in head and neck squamous cell carcinoma

Arch Otolaryngol Head Neck Surg. 2005 May;131(5):418-29.
"An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma."
Author(s): Yoo GH, Subramanian G, Boinpally RR, Iskander A, Shehadeh N, Oliver J, Ezzat W, Piechocki MP, Ensley JF, Lin HS, Shibuya TY, Polin L, Parchment RE
Number of Citations: 1
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to investigate the effect of valproate on Ara-C cytotoxicity in acute myeloblastic leukemia cells and its mechanism

Leuk Res. 2005 Nov;29(11):1335-42.
"Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells."
Author(s): Siitonen T, Koistinen P, Savolainen ER
Number of Citations: 4
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in flow cytometry, flow cytometry, immunocytochemistry, immunocytochemistry, western blot, and western blot to investigate the inhibitory effect of N-(4-hydrophenyl) retinamide on hepatocellular carcinoma cells and malignant melanoma

World J Gastroenterol. 2005 Oct 7;11(37):5763-9.
"Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells."
Author(s): Wu XZ, Zhang L, Shi BZ, Hu P
Number of Citations: 0
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to examine the therapeutic effect of N-all-trans-retinoyl-L-proline in the metastasis of hepatocellular carcinoma cells

Cell Biol Int. 2006 Aug;30(8):672-80.
"N-all-trans-retinoyl-L-proline inhibits metastatic potential of hepatocellular carcinoma cells."
Author(s): Wu XZ, Shi PC, Hu P, Chen Y, Ding SS
Number of Citations: 2
(See PubMed article )
  Hu / 1:500
MA5-12835 was used in western blot to study the role of p21(Cip1) and p27(Kip1) in the induction of cell cycle arrest in human panceatic adenocarcinoma cells by isoprenoids

J Pharmacol Exp Ther. 2007 Mar;320(3):1163-70.
"Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells."
Author(s): Wiseman DA, Werner SR, Crowell PL
Number of Citations: 9
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to investigate the mechanism for the antitumor activity of 5-Chloro-N-[2-[2-(4-chloro-phenyl)-3-methyl-butoxy]-5-trifluoromethyl-phenyl]-2-hydroxy-benzamide in head and neck cancer cell lines

Mol Cancer Ther. 2007 Jun;6(6):1898-908.
"Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-kappaB expression and proteasome activation in head and neck squamous carcinoma cell lines."
Author(s): Skvortsov S, Skvortsova I, Stasyk T, Schiefermeier N, Neher A, Gunkel AR, Bonn GK, Huber LA, Lukas P, Pleiman CM, Zwierzina H
Number of Citations: 2
(See PubMed article )
  Hu / 1:1000
MA5-12835 was used in western blot to study the role of heparan and chondroitin sulfate signaling in the osteogenic differentiation of mesenchymal stem cells

Stem Cells. 2007 Nov;25(11):2845-54.
"Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways."
Author(s): Manton KJ, Leong DF, Cool SM, Nurcombe V
Number of Citations: 18
(See PubMed article )
  Hu / 1:1000
MA5-12835 was used in western blot to study the molecular mechanism of hepatocellular carcinoma development induced by hepatitis B virus X protein

Intervirology. 2008;51(1):50-8.
"Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene."
Author(s): Ye L, Dong N, Wang Q, Xu Z, Cai N, Wang H, Zhang X
Number of Citations: 2
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to study the role of BAF180 in regulating p21 expression in breast cancer

Cancer Res. 2008 Mar 15;68(6):1667-74.
"BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer."
Author(s): Xia W, Nagase S, Montia AG, Kalachikov SM, Keniry M, Su T, Memeo L, Hibshoosh H, Parsons R
Number of Citations: 34
(See PubMed article )
  Hu / 1:100
MA5-12835 was used in western blot to examine the effect of penta-O-galloyl-beta-D-glucose on prostate cancer cell proliferation

Carcinogenesis. 2009 May;30(5):818-23.
"Penta-O-galloyl-beta-D-glucose induces S- and G(1)-cell cycle arrests in prostate cancer cells targeting DNA replication and cyclin D1."
Author(s): Hu H, Zhang J, Lee HJ, Kim SH, Lü J
Number of Citations: 5
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in western blot to study the mechanism by which microRNA-223 attenuates cell proliferation

PLoS One. 2011;6(11):e27008.
"MiR-223 suppresses cell proliferation by targeting IGF-1R."
Author(s): Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao QL, Wu W, Wu XZ
Number of Citations: 10
(See PubMed article )
  Ms / 1:200
MA5-12835 was used in immunohistochemistry and western blot to investigate the role of the p27(kip1) during spermatogonial processes

Endocrinology. 1999 Apr;140(4):1834-40.
"Regulatory role of p27kip1 in the mouse and human testis."
Author(s): Beumer TL, Kiyokawa H, Roepers-Gajadien HL, van den Bos LA, Lock TM, Gademan IS, Rutgers DH, Koff A, de Rooij DG
Number of Citations: 6
(See PubMed article )
  Ms / Not Cited
MA5-12835 was used in western blot to study the role of CDK4 in cell cycle regulation using targeted knockdown

Mol Cell Biol. 1999 Oct;19(10):7011-9.
"Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity."
Author(s): Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H
Number of Citations: 88
(See PubMed article )
  Ms / Not Cited
MA5-12835 was used in immunohistochemistry and western blot to investigate the expression patterns of cell cycle inhibitors in the adult brain

Neuroreport. 2001 Oct 8;12(14):3127-31.
"Region-specific expression of cell cycle inhibitors in the adult brain."
Author(s): Legrier ME, Ducray A, Propper A, Kastner A
Number of Citations: 4
(See PubMed article )
  Ms / Not Cited
MA5-12835 was used in western blot to investigate the mechanism of photocarcinogenesis prevention by silibinin

Cancer Res. 2004 Sep 1;64(17):6349-56.
"Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling."
Author(s): Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R
Number of Citations: 1
(See PubMed article )
  Ms / Not Cited
MA5-12835 was used in flow cytometry, flow cytometry, immunocytochemistry, immunocytochemistry, western blot, and western blot to investigate the inhibitory effect of N-(4-hydrophenyl) retinamide on hepatocellular carcinoma cells and malignant melanoma

World J Gastroenterol. 2005 Oct 7;11(37):5763-9.
"Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells."
Author(s): Wu XZ, Zhang L, Shi BZ, Hu P
Number of Citations: 0
(See PubMed article )
Immunocytochemistry
  Species / Dilution Summary
  Hu / 1:50-100
MA5-12835 was used in immunocytochemistry to study the presence and significance of p27Kip1 in detergent-insoluble microdomains within lymphocyte membranes

Mol Med. 2001 Jan;7(1):49-58.
"p27Kip1 localizes to detergent-insoluble microdomains within lymphocyte membranes."
Author(s): Yaroslavskiy BB, Stolz DB, Watkins SC, Alber SM, Bradbury NA, Steinman RA
Number of Citations: 0
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in flow cytometry, immunocytochemistry, and western blot to study changes in the expression of the 24kDa C-terminal p27kip1 variant upon lymphocyte activation

J Cell Biochem. 2001 Aug 21-Sep 5;83(3):380-9.
"Dynamic changes in p27kip1 variant expression in activated lymphocytes."
Author(s): Yaroslavskiy B, Watkins SC, Alber S, Steinman RA
Number of Citations: 1
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in flow cytometry, flow cytometry, immunocytochemistry, immunocytochemistry, western blot, and western blot to investigate the inhibitory effect of N-(4-hydrophenyl) retinamide on hepatocellular carcinoma cells and malignant melanoma

World J Gastroenterol. 2005 Oct 7;11(37):5763-9.
"Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells."
Author(s): Wu XZ, Zhang L, Shi BZ, Hu P
Number of Citations: 0
(See PubMed article )
  Hu / 0
MA5-12835 was used in immunocytochemistry to study the role of inflammatory mediators of esophagitis in altered p27(Kip1) expression in esophageal epithelial cells

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):556-62.
"Inflammatory mediators of esophagitis alter p27 Kip1 expression in esophageal epithelial cells."
Author(s): Nguyen KD, Blain SW, Gress F, Treem WR
Number of Citations: 0
(See PubMed article )
  Ms / 1:200
MA5-12835 was used in immunocytochemistry to evaluate an invitro cell culture system for the study of mammalian sensory hair cell growth and differentiation

Dev Biol. 2004 Aug 15;272(2):432-47.
"In vitro growth and differentiation of mammalian sensory hair cell progenitors: a requirement for EGF and periotic mesenchyme."
Author(s): Doetzlhofer A, White PM, Johnson JE, Segil N, Groves AK
Number of Citations: 16
(See PubMed article )
  Ms / Not Cited
MA5-12835 was used in flow cytometry, flow cytometry, immunocytochemistry, immunocytochemistry, western blot, and western blot to investigate the inhibitory effect of N-(4-hydrophenyl) retinamide on hepatocellular carcinoma cells and malignant melanoma

World J Gastroenterol. 2005 Oct 7;11(37):5763-9.
"Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells."
Author(s): Wu XZ, Zhang L, Shi BZ, Hu P
Number of Citations: 0
(See PubMed article )
Immunohistochemistry
  Species / Dilution Summary
  Hu / 1:150
MA5-12835 was used in immunohistochemistry to investigate the prognostic significance of the p27(Kip1) in advanced epithelial ovarian cancer

Clin Cancer Res. 2000 Dec;6(12):4816-22.
"p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis."
Author(s): Masciullo V, Ferrandina G, Pucci B, Fanfani F, Lovergine S, Palazzo J, Zannoni G, Mancuso S, Scambia G, Giordano A
Number of Citations: 3
(See PubMed article )
  Hu / 1:800
MA5-12835 was used in immunohistochemistry to evaluate cyclin E and p27 as developmental markers for endometrium

Fertil Steril. 2003 Jul;80(1):146-56.
"Improved endometrial assessment using cyclin E and p27."
Author(s): Dubowy RL, Feinberg RF, Keefe DL, Doncel GF, Williams SC, McSweet JC, Kliman HJ
Number of Citations: 1
(See PubMed article )
  Hu / 1:200
MA5-12835 was used in immunohistochemistry to investigate the influence of Bcl-2 reduction on the progression and prognosis of human IgA nephropathy

J Am Soc Nephrol. 2004 Jan;15(1):79-90.
"Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy."
Author(s): Qiu LQ, Sinniah R, I-Hong Hsu S
Number of Citations: 2
(See PubMed article )
  Hu / 1:150
MA5-12835 was used in immunohistochemistry to study the expression of pRb2/p130, VEGF, p27(KIP1), and PCNA as potential markers of hepatocellular carcinoma

Clin Cancer Res. 2004 May 15;10(10):3509-17.
"pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance."
Author(s): Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A
Number of Citations: 2
(See PubMed article )
  Hu / 1:100
MA5-12835 was used in immunohistochemistry to evaluate immunohistochemical markers of non-small cell lung cancer using unsupervised hierarchical clustering analysis

J Pathol. 2004 Sep;204(1):101-9.
"Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers."
Author(s): Au NH, Cheang M, Huntsman DG, Yorida E, Coldman A, Elliott WM, Bebb G, Flint J, English J, Gilks CB, Grimes HL
Number of Citations: 11
(See PubMed article )
  Hu / 1:50
MA5-12835 was used in immunohistochemistry to study the expression of p8 protein in breast carcinoma and its relationship with apoptosis

Anticancer Res. 2005 Mar-Apr;25(2A):833-7.
"Expression of p8 protein in breast carcinoma; an inverse relationship with apoptosis."
Author(s): Ito Y, Yoshida H, Motoo Y, Iovanna JL, Nakamura Y, Kakudo K, Uruno T, Takamura Y, Miya A, Noguchi S, Kuma K, Miyauchi A
Number of Citations: 5
(See PubMed article )
  Hu / 1:40
MA5-12835 was used in immunohistochemistry to study the role of SKP2 and CKS1 in the progression of human urothelial carcinoma

J Urol. 2007 Jul;178(1):301-7.
"Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma."
Author(s): Kawakami K, Enokida H, Tachiwada T, Nishiyama K, Seki N, Nakagawa M
Number of Citations: 5
(See PubMed article )
  Hu / 1:200
MA5-12835 was used in immunohistochemistry to study the mechanisms driving increased expression of C/EBPbeta in proliferative inflammatory atrophy of the prostate

Prostate. 2007 Aug 1;67(11):1238-46.
"Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation."
Author(s): Wang W, Bergh A, Damber JE
Number of Citations: 2
(See PubMed article )
  Hu / 1:50
MA5-12835 was used in immunohistochemistry to study the prognostic significance of the expression of cyclin B1, p34cdc2, p27(Kip1) and p53 in gastric cancer

Yonsei Med J. 2007 Aug 31;48(4):694-700.
"Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer."
Author(s): Kim DH
Number of Citations: 2
(See PubMed article )
  Hu / 1:400
MA5-12835 was used in immunohistochemistry to evaluate different fixation and antigen retrieval methods for immmunohistochemical studies on frozen tissues

Am J Clin Pathol. 2008 Mar;129(3):358-66.
"Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry."
Author(s): Shi SR, Liu C, Pootrakul L, Tang L, Young A, Chen R, Cote RJ, Taylor CR
Number of Citations: 1
(See PubMed article )
  Hu / 1:50
MA5-12835 was used in immunohistochemistry to study the expression of senescence-related genes in human corneal endothelial cells from donors of different ages

Mol Vis. 2008 Jan 29;14():161-70.
"Expression of senescence-related genes in human corneal endothelial cells."
Author(s): Song Z, Wang Y, Xie L, Zang X, Yin H
Number of Citations: 13
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in immunohistochemistry to study the prognostic value of high expression of both cyclin E and Skp2 in basal phenotype breast cancer

Hum Pathol. 2008 Oct;39(10):1431-7.
"The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype."
Author(s): Voduc D, Nielsen TO, Cheang MC, Foulkes WD
Number of Citations: 8
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in immunohistochemistry to examine the prognostic significance of activated AKT in gastric cancer

Virchows Arch. 2008 Nov;453(5):449-55.
"Activated Akt as an indicator of prognosis in gastric cancer."
Author(s): Cinti C, Vindigni C, Zamparelli A, La Sala D, Epistolato MC, Marrelli D, Cevenini G, Tosi P
Number of Citations: 7
(See PubMed article )
  Hu / Not Cited
MA5-12835 was used in immunohistochemistry to study the expression and potential role of TNFR2 in human and experimental renal allograft rejection

Am J Transplant. 2009 Apr;9(4):675-86.
"Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection."
Author(s): Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Rümmele P, Stoelcker B, Banas B, Männel DN, Krämer BK
Number of Citations: 4
(See PubMed article )
  Hu / 1:100
MA5-12835 was used in immunohistochemistry to investigate the mechanism for cellular susceptibility to Herceptin

Breast Cancer Res. 2009;11(4):R50.
"Presence of HER4 associates with increased sensitivity to Herceptin in patients with metastatic breast cancer."
Author(s): Sassen A, Diermeier-Daucher S, Sieben M, Ortmann O, Hofstaedter F, Schwarz S, Brockhoff G
Number of Citations: 1
(See PubMed article )
  Ms / 1:200
MA5-12835 was used in immunohistochemistry and western blot to investigate the role of the p27(kip1) during spermatogonial processes

Endocrinology. 1999 Apr;140(4):1834-40.
"Regulatory role of p27kip1 in the mouse and human testis."
Author(s): Beumer TL, Kiyokawa H, Roepers-Gajadien HL, van den Bos LA, Lock TM, Gademan IS, Rutgers DH, Koff A, de Rooij DG
Number of Citations: 6
(See PubMed article )
  Ms / Not Cited
MA5-12835 was used in immunohistochemistry and western blot to investigate the expression patterns of cell cycle inhibitors in the adult brain

Neuroreport. 2001 Oct 8;12(14):3127-31.
"Region-specific expression of cell cycle inhibitors in the adult brain."
Author(s): Legrier ME, Ducray A, Propper A, Kastner A
Number of Citations: 4
(See PubMed article )
  Ms / 1:100
MA5-12835 was used in immunohistochemistry to investigate the role of Math1 in the development of hair cells in inner ear

Development. 2002 May;129(10):2495-505.
"The role of Math1 in inner ear development: Uncoupling the establishment of the sensory primordium from hair cell fate determination."
Author(s): Chen P, Johnson JE, Zoghbi HY, Segil N
Number of Citations: 69
(See PubMed article )
  Ms / 1:100
MA5-12835 was used in immunohistochemistry to study Islet1 expression as a marker of sensory and neuronal cell lineage in the mammalian inner ear

J Comp Neurol. 2004 Sep 27;477(4):412-21.
"Expression of Islet1 marks the sensory and neuronal lineages in the mammalian inner ear."
Author(s): Radde-Gallwitz K, Pan L, Gan L, Lin X, Segil N, Chen P
Number of Citations: 19
(See PubMed article )
  Ms / 1:200
MA5-12835 was used in immunohistochemistry to investigate the progenitors of hair cells and supporting cells from embryonic mouse cochlea

Brain Res. 2006 May 26;1091(1):282-8.
"Prospective identification and purification of hair cell and supporting cell progenitors from the embryonic cochlea."
Author(s): Doetzlhofer A, White P, Lee YS, Groves A, Segil N
Number of Citations: 3
(See PubMed article )
Flow Cytometry
  Species / Dilution Summary
  Hu / Not Cited
MA5-12835 was used in flow cytometry, immunocytochemistry, and western blot to study changes in the expression of the 24kDa C-terminal p27kip1 variant upon lymphocyte activation

J Cell Biochem. 2001 Aug 21-Sep 5;83(3):380-9.
"Dynamic changes in p27kip1 variant expression in activated lymphocytes."
Author(s): Yaroslavskiy B, Watkins SC, Alber S, Steinman RA
Number of Citations: 1
(See PubMed article )
  Hu / Not Cited
Ms / Not Cited
MA5-12835 was used in flow cytometry, flow cytometry, immunocytochemistry, immunocytochemistry, western blot, and western blot to investigate the inhibitory effect of N-(4-hydrophenyl) retinamide on hepatocellular carcinoma cells and malignant melanoma

World J Gastroenterol. 2005 Oct 7;11(37):5763-9.
"Inhibitory effects of N-(4-hydrophenyl) retinamide on liver cancer and malignant melanoma cells."
Author(s): Wu XZ, Zhang L, Shi BZ, Hu P
Number of Citations: 0
(See PubMed article )
Immunoprecipitation
  Species / Dilution Summary
  Hu / 2 ug/time
MA5-12835 was used in immunoprecipitation and western blot to study the mechanisms by which IGF-1 confers resistance to the growth-inhibiting actions of Herceptin

Int J Cancer. 2004 Jan 20;108(3):334-41.
"Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells."
Author(s): Lu Y, Zi X, Pollak M
Number of Citations: 26
(See PubMed article )
  N/A / Not Cited
MA5-12835 was used in immunoprecipitation to study if the growth state-dependent tyrosine phosphorylation of p27Kip1 determines whether or not it inhibits cdk4

Mol Cell Biol. 2008 Jan;28(1):498-510.
"Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity."
Author(s): James MK, Ray A, Leznova D, Blain SW
Number of Citations: 27
(See PubMed article )
(This product is for In Vitro experimental use only. Not for resale without express authorization.)
Part of Thermo Fisher Scientific